Table 4.
Comparison of laboratory abnormalities among AFL, NAFL and control groups (%)
| Biochemical Index | AFL group (n = 28) | NAFL group (n = 301) | Control group (n = 163) |
| TG (≥ 1.7 mmol/L) | 2(7.1)a | 169(56.2)c | 27(17.7) |
| CHOL (≥ 5.2 mmol/L) | 2(7.1)a | 148(49.2)c | 35(22.9) |
| HDL-C (≤ 1.0 mmol/L) | 9(32.1)a | 35(11.6) | 27(17.7) |
| LDL-C (≥ 2.6 mmol/L) | 12(42.9)a | 214(71.1) | 97(63.4) |
| Apo AI (≤ 1.2 mmol/L) | 13(46.4) | 118(39.2) | 45(29.4) |
| Apo B (≥ 1.1 mmol/L) | 4(14.3)ac | 149(49.5)e | 53(34.6) |
| UA (≥ 452 mg/dL) | 5(17.9) | 89(29.6)e | 18(11.8) |
| AST (≥ 40 U) | 12(42.9)ac | 51(16.9) | 24(15.7) |
| ALT (≥ 40 U) | 10(35.7)c | 87(28.9)e | 26(17.0) |
| AST/ALT ( < 1) | 11(39.3)c | 168(55.8)e | 31(20.3) |
| (≥ 2) | 5(17.9)a | 15(5.0)e | 40(26.1) |
| ALB (≤ 35 g/L) | 3(10.7) | 9(3.0) | 7(4.6) |
| GLB (≥ 30 g/L) | 3(10.7) | 32(10.6) | 20(13.1) |
| A/G (≤ 1.5) | 7(25.0) | 64(21.3) | 31(20.3) |
| GGT (≥ 50 U/L) | 10(35.7) | 95(31.6)e | 30(19.6) |
| TBIL (≥ 17.1 μmol/L) | 6(21.4) | 50(16.6) | 30(19.6) |
a
P < 0.05, vs NAFL group;
c
P < 0.05, vs control group;
e
P < 0.05, vs control group.